Maze Therapeutics Inc. (MAZE) is a clinical-stage biopharmaceutical company developing a drug for APOL1-mediated kidney disease (AMKD) for which there are currently no FDA-approved therapies.
This is a summary. For the full story, refer to the original source. Public of India presents verified citizen-relevant reporting.